Martine A. Rothblatt, Ph.D., J.D., M.B.A.
- Chairman and Chief Executive Officer
Dr. Rothblatt founded United Therapeutics in 1996 and has served as Chairman and
Chief Executive Officer since its inception. Prior to United Therapeutics, she founded
and served as Chairman and Chief Executive Officer of Sirius XM Satellite Radio.
She also represented the radio astronomy interests of the National Academy of Sciences’
Committee on Radio Frequencies before the Federal Communications Commission and
led the International Bar Association’s efforts to present the United Nations with
a draft Human Genome Treaty. Her book, YOUR LIFE OR MINE: HOW GEOETHICS CAN RESOLVE
THE CONFLICT BETWEEN PUBLIC AND PRIVATE INTERESTS IN XENOTRANSPLANTATION, was published
by Ashgate in 2004. She is a co-inventor on three of our patents pertaining to treprostinil.
She has served as a United Therapeutics director since 1996.
Roger Jeffs, Ph.D.
- President and Chief Operating Officer
Dr. Jeffs received his undergraduate degree in chemistry from Duke University and
his Ph.D. in pharmacology from the University of North Carolina. Dr. Jeffs joined
United Therapeutics in September 1998 as Director of Research, Development and Medical.
Dr. Jeffs was promoted to Vice President of Research, Development and Medical in
July 2000, and to his current position of President and Chief Operating Officer
in April 2001. From 1993 to 1995, Dr. Jeffs worked at Burroughs Wellcome & Company
where he was a member of the clinical research team that developed Flolan®, the
first FDA-approved therapy for patients with pulmonary arterial hypertension. From
1995 to 1998, Dr. Jeffs worked at Amgen, Inc. where he served as the worldwide clinical
leader of the Infectious Disease Program. Dr. Jeffs currently leads our global clinical,
commercial, manufacturing and business development efforts. He has served as a United
Therapeutics director since 2002.
John M. Ferrari
- Chief Financial Officer & Treasurer
John M. Ferrari joined United Therapeutics in May 2001 as Controller. Mr. Ferrari
was promoted to Vice President of Finance in December 2003 and to Vice President
of Finance and Treasurer in June 2004. In August 2006 Mr. Ferrari was promoted to
Chief Financial Officer and Treasurer. Prior to joining United Therapeutics, Mr.
Ferrari served as Controller for Blackboard, Inc., from 1998 to 2001. Prior to his
employment with Blackboard, Inc., Mr. Ferrari served in various senior financial
management positions since beginning his accounting career in 1984.
Paul A. Mahon, J.D.
- Executive Vice President, General Counsel & Corporate Secretary
Paul A. Mahon, J.D., has served as General Counsel and Corporate Secretary of United
Therapeutics since its inception in 1996. In June 2001, Mr. Mahon joined United
Therapeutics full-time as Senior Vice President, General Counsel and Corporate Secretary.
In November 2003, Mr. Mahon was promoted to Executive Vice President, General Counsel
and Corporate Secretary. Prior to June 2001, he served United Therapeutics, beginning
with its formation in 1996, in his capacity as principal and managing partner of
a law firm specializing in technology and media law.
United Therapeutics Corporation